A new technique for monitoring the disease on HIV sufferers has been developed by Australian scientists. This test is cheap price wise, thus will be a soothing thing for the HIV sufferers from any country. This test has been developed by the researchers at Melbourne based Macfarlane Burnet Institute, and will enable the experts to monitor the key CD4 T cells in people with HIV virus.
These cells are perfect and true indicators of development in the disease, and are a major target of HIV virus. By targeting these cells, HIV reduces their level. Not only this, but it weakens the immunity system of the victim that gives rise to AIDS.
40 million people around the globe have been diagnosed with HIV. Three million new cases are diagnosed every year. Currently, the monitoring technique is quite expensive and pricey. This technique uses flow cytometry, and is available in limited laboratories. In these circumstances, this new inexpensive test is a ray of hope for HIV inflicted people.
Initial validation state of this technology has been achieved with the funding by the Doris Duke Charitable Foundation and the National Health and Medical Research Council. Research on the ELISA (enzyme-linked immunosorbent assay) based test has been led by Associate Professor David Anderson and Professor Suzanne Crowe. Researchers have established a company with the name of SeeD4. The received funds have reached up to $377,000 from the Medical Research Commercialization Fund (MRCF) and a $30 million fund supported by the Victorian Government. This innovative creation has been announced by Victorian Innovation Minister Gavin Jennings, who said, “The Victorian Government is taking action to promote health and lifestyle benefits through biotech initiatives, such as this new HIV test, which will also create jobs for Victorians.”